[1] 王慧,贾继东.慢性HBV感染自然史及治疗对转归的影响[J].首都医科大学学报,2010,31(5):582-585.[2] Lu F M, Zhuang H. Management of hepatitis B in China[J]. Chin Med J(Engl), 2009,122(1):3-4.[3] Kvakan H, Kleinewietfeld M, Qadri F, et al. Regulatory T cells ameliorate angitensin Ⅱ-induced cardiac damage[J]. Circulation, 2009,119(22):2904-2912.[4] Claassen M A, de Knegt R J, Tilanus H W, et al. Abundant number of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis[J]. J Hepatol, 2010,52(3):315-321.[5] Ghiringhelli F, Ménard C, Terme M, et al. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner[J]. J Exp Med, 2005,202(8):1075-1085.[6] Bendelac A, Savage P B, Teyton L. The biology of NKT cells[J]. Annu Rev Immunol, 2007,25:297-336.[7] Hong H, Gu Y, Zhang H, et al. Depletion of CD4+CD25+ regulatory T cells enhances natural killer T cell-mediated anti-tumour immunity in amurine mammary breast cancer model[J]. Clin Exp Immunol, 2010,159(1):93-99.[8] Strauss L, Bergmann C, Szczepanski M, et al. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta 1 mediates suppression in the tumor microenvironment[J]. Clin Cancer Res, 2007,13(15 Pt 1):4345-4354.[9] Zhou H, Chen L, You Y, et al. Foxp3-transduced polyclonal regulatory T cells suppress NK cell functions in a TGF-β dependent manner[J]. Autoimmunity, 2010,43(4):299-307. |